中國平安(02318.HK)去年賠付總件數超2億件 涉逾2,800億人幣
中國平安(02318.HK)發布2022年度保險理賠報告。去年,中國平安旗下4家保險公司賠付總件數超2億件,平均每天賠付超60萬件;其中,平安人壽賠付410萬件、平安產險賠付1.9億件、平安養老險賠付1,599萬件,平安健康險賠付245萬件。賠付總金額超2,800億元人民幣,相當於每天賠付7.7億元。
平安指,從理賠資料中發現,去年最危險的三大重疾分別為惡性腫瘤、急性心肌梗死、腦中風後遺症;客戶需求發生改變,從「事後被動理賠」轉為「前置就醫服務、主動健康管理」;老齡化趨勢下,數字化升級驅動適老化理賠服務勢在必行;科技與人工智慧技術將進一步推動理賠服務變革,使客戶體驗更加簡單、便捷、高效;以「誠信平台」為基礎助推理賠提速,未來免材料、免審核佔比進一步提升等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.